The Global sodium acetate trihydrate & sodium acetate anhydrous Market is estimated to be valued at US$ 136.98 Bn in 2024 and is expected to exhibit a CAGR of 9.5% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Sodium Acetate Trihydrate & Anhydrous Market are AbbVie Inc., Ablynx NV by Sanofi SA, Arrowhead Pharmaceuticals, Inc., Baxter International Inc., AstraZeneca PLC, Boston Scientific Corporation, Becton, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC., Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Vectura Group PLC, Taiwan Liposome Company, Ltd., and 3M Company. The increasing demand for packaged and processed food items around the world is propelling the sodium acetate trihydrate & sodium acetate anhydrous market growth. Technological advancements have allowed manufacturers to develop newer formulation techniques for sodium acetate salts with improved stability and antimicrobial effectiveness.

Get more insights on Sodium Acetate Market